openPR Logo
Press release

Omeprazole Market Size, Share, Growth, Trends, Analysis and Forecast - 2028

06-02-2022 03:05 PM CET | Health & Medicine

Press release from: Orion Market Reports

The global omeprazole market is anticipated to grow at a CAGR of 5.1% during the forecast period (2022-2028).

Omeprazole, is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. Omeprazole is a medicine that can be used alone or in conjunction with other medications. It is used to treat GERD, ulcers, and other disorders brought on by too much stomach acid. The market is growing due to an increase in the number of individuals suffering from gastrointestinal problems. According to a blog by GI Alliance, in February 2021, the digestive problem affects 62 million Americans every year. Most digestive illnesses become more common as people get older. Hemorrhoids, inflammatory bowel disease, and chronic liver disease are further outliers, that are more common in young and middle-aged persons owing to such factors the market is witnessing positive growth.

Click Here to Get a Free Sample Report of the Omeprazole Market @ https://orionmarketreports.com/request-sample/?id=111412&submit=Request+Sample%0D%0A

Some major players in the market include RedHill Biopharma Ltd., Dr. Reddy's Laboratories Ltd., AstraZeneca, Mylan N.V., Apotex, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. Additionally, an increase in the number of FDA-approved drugs boosted the market growth of omeprazole. For instance, in December 2018, Dr. Reddy has launched Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec OTC (omeprazole delayed-release) Tablets, 20 mg, in the US market, following FDA approval (USFDA). Omeprazole Delayed-Release Tablets, 20 mg, is an over-the-counter proton pump inhibitor used to treat frequent heartburn in individuals who experience it two or more times per week.

Get 15% Discount on Buying this Report: https://orionmarketreports.com/request-discount/?id=111412&submit=Request+Discount

The use of omeprazole is increasing due to the rising prevalence of acid reflux, respiratory illnesses, and heart-related problems. The use of omeprazole is increasing as the number of incidences of duodenal and peptic ulcers rises. Furthermore, rising healthcare expenditures, increased research and development operations by numerous pharmaceutical companies, and the introduction of novel developed drugs all contribute to the omeprazole market's growth. In March 2019, Talicia for H. pylori infection has commercially launched in the US by RedHill Biopharma Ltd. Taliciais a new fixed-dose oral capsule that combines two antibiotics (amoxicillin and rifabutin) with a PPI (omeprazole).

A full report of Global Omeprazole Market is available at: https://orionmarketreports.com/omeprazole-market/111412/

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Dosage Form
o By Indication
o By Distribution Channel

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Apotex, AstraZeneca, Dr. Reddy's Laboratories Ltd., Mylan N.V., RedHill Biopharma Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Omeprazole Market Report by Segment

By Dosage Form
• Capsule
• Powder
• Tablet

By Indication
• Duodenal Ulcer
• Gastric Ulcer
• Gastroesophageal Reflux Disease (GERD)

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Omeprazole Market Size, Share, Growth, Trends, Analysis and Forecast - 2028 here

News-ID: 2643820 • Views:

More Releases from Orion Market Reports

Diabetic Neuropathic Pain Drug Market Sluggish Growth Rate Foreseen by 2024-2031
Diabetic Neuropathic Pain Drug Market Sluggish Growth Rate Foreseen by 2024-2031
The Diabetic Neuropathic Pain Drug Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2024-2031). Diabetic neuropathic pain is a chronic condition resulting from nerve damage caused by diabetes, leading to symptoms such as burning, tingling, and numbness, particularly in the feet and hands. The Diabetic Neuropathic Pain Drug Market focuses on treatments designed to manage and alleviate these painful symptoms. Effective
Mantle Cell Lymphoma Treatment Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Mantle Cell Lymphoma Treatment Market is Anticipated to Increase at a Stable CAG …
The Mantle Cell Lymphoma Treatment Market size is expected to grow at an annual average of CAGR 7% during the forecast period (2024-2031). Mantle Cell Lymphoma (MCL) is a rare and aggressive type of non-Hodgkin lymphoma that arises from the B-cells in the outer edge of a lymph node follicle, known as the mantle zone. It is characterized by a poor prognosis and a high likelihood of relapse, making the
Allergic Asthma Therapeutics Market to Signify Strong Growth by 2024-2031
Allergic Asthma Therapeutics Market to Signify Strong Growth by 2024-2031
The Allergic Asthma Therapeutics Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The Allergic Asthma Therapeutics Market focuses on pharmaceuticals and treatments designed to manage and alleviate symptoms associated with allergic asthma, a type of asthma triggered by allergens such as pollen, dust mites, pet dander, or mold. Allergic asthma is characterized by airway inflammation and hyperreactivity, leading to symptoms
Seasonal Allergic Rhinitis Drug Market Is Likely to Experience a Tremendous Growth by 2031
Seasonal Allergic Rhinitis Drug Market Is Likely to Experience a Tremendous Grow …
The Seasonal Allergic Rhinitis Drug Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The Seasonal Allergic Rhinitis Drug Market focuses on pharmaceuticals and treatments designed to alleviate symptoms associated with seasonal allergic rhinitis, commonly known as hay fever. Seasonal allergic rhinitis is an allergic reaction to specific allergens, such as pollen from trees, grasses, or weeds, that occurs primarily during

All 5 Releases


More Releases for Omeprazole

Omeprazole Market 2022 Key Drivers - AstraZeneca AB, Sandoz, Actavis, Teva
MRInsights.biz recently finished a Global Omeprazole Market search that includes product specifics, market segmentation, and other information. During the forecast period, the study looks at the global Omeprazole market, including market trends, size, value, and compound and annual growth rates. The market development patterns for this area are forecasted in this report. The market analysis considers the geographic scope, market segmentation, growth drivers, and market restraints of worldwide Omeprazole businesses. The
Omeprazole Market - Increasing prevalence of peptic ulcers is expected to propel …
The report presents an in-depth assessment of the Omeprazole Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the
Omeprazole Market: 2018 Global Market Growth, Trends, Size & 2025 Forecasts
Global Omeprazole Market Insights, Forecast to 2025 report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Synthetic Pigments market based on technology, solution, and application. Download PDF Brochure of Omeprazole Market spread across 114 Pages, Profiling 12 Companies and Supported with tables and figures are now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1744885 This study categorizes the global Omeprazole breakdown data
Global Omeprazole Market Scope, trends, growth and Opportunities Analysis 2023
Research N Reports has announced the addition of a new market intelligence report. The report is titled, “Global Omeprazole Market Size, Status and Forecast 2023”. The report comprises of the market growth figures since last few years and the estimated growth trajectory for the coming future. The report also examines the factors accountable for the modification in the market and the rise in the requirement. It represents it through a
Global Omeprazole Sales Market Report 2016 - Apotex, Sandoz, Astrazeneca, Santar …
This report studies sales (consumption) of Omeprazole in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Apotex Dr reddys laboratories Impax laboratories Kremers urban development Lek pharmaceuticals Mylan pharmaceuticals Sandoz Watson laboratories Astrazeneca Dexcel pharma technologies Santarus Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share
Proton Pump Inhibitors (PPIs) Market 2017 - Pantoprazole, Omeprazole, Lansoprazo …
Worldwide Proton Pump Inhibitors (PPIs) Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Proton Pump Inhibitors (PPIs) piece of the overall industry and Growth patterns, concentrating on driving Proton Pump Inhibitors (PPIs) industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022. Get Free Sample Copy of Report Here: https://goo.gl/ydpu7k Top Manufacturers Analysis of This Report AstraZeneca, Pfizer, Janssen, Eisai, Eli Lilly, Cadila Pharmaceuticals, Santarus,